The promise of personalized medicine: a conversation with Michael Svinte. Interview by Michael Millenson.
In early 2004, IBM combined its Healthcare unit, which focused on the technology needs of providers, with its Life Sciences unit, which catered to research scientists. Out of that union was born an "emerging business opportunity" called information-based medicine, in which IBM has already invested tens of millions in the expectation of reaping billions of dollars in revenues. Michael Svinte describes his mission as providing the information technology infrastructure that will enable technologies such as proteomics and molecular imaging to progress from the bench to the bedside, thereby resulting in predictive and personalized health care.
Svinte
Michael
M
D000046:Academic Medical Centers / Q000458:organization & administration; D019295:Computational Biology; D003219:Confidentiality; D030661:Genetic Privacy; D006801:Humans; D007221:Industry / Q000458:organization & administration / Q000639:trends; D008490:Medical Informatics / Q000191:economics; D018802:Patient-Centered Care; D010597:Pharmacogenetics / Q000639:trends*; D019095:Point-of-Care Systems; D040901:Proteomics; D012985:Software Design; D018511:Systems Integration; D014481:United States